Press release
Rare Diseases Market to Reach USD 414.62 Billion by 2034 Driven by Gene Therapies
Pune, India - December 2025 - The global Rare Diseases Market, valued at USD 218.34 billion in 2024, is projected to reach USD 414.62 billion by 2034, expanding at a 6.7% CAGR (2025-2034), according to Exactitude Consultancy. Rising approvals of orphan drugs, strong growth in gene and cell therapies, and increased patient advocacy are fueling rapid market expansion.Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73179
Market Summary
The Rare Diseases Market continues to grow significantly as pharmaceutical and biotech companies intensify R&D efforts across over 7,000+ identified rare diseases, many of which still lack approved treatments. Major innovation is focused on gene therapies, AAV & lentiviral vectors, antisense oligonucleotides (ASOs), enzyme replacement therapies (ERTs), monoclonal antibodies, small molecules, and RNA-based therapeutics.
Advances in genomic sequencing and newborn screening are improving early detection, while global regulatory incentives-such as the FDA Orphan Drug Act, EMA PRIME, and Japan's Sakigake pathway-are accelerating drug development timelines. North America dominates the market, while Asia-Pacific is the fastest-growing region driven by expanding rare disease awareness and increasing access to advanced therapies.
Key Takeaways
• 2024 Market Size: USD 218.34 Billion
• 2034 Forecast: USD 414.62 Billion
• CAGR: 6.7% (2025-2034)
• Strong pipeline of gene & cell therapies targeting ultra-rare genetic disorders
• Regulatory incentives boosting orphan drug approvals globally
• Rising patient advocacy and rare disease registries improving clinical trial participation
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73179/rare-diseases-market
Market Drivers
• Increasing investment in precision and genomic medicine
• Advancements in CRISPR, AAV gene therapy, and mRNA technologies
• High unmet clinical need across metabolic, neurological & genetic disorders
• Growing collaborations between biotech startups, academia, and big pharma
• Expansion of reimbursement frameworks supporting high-cost orphan drugs
Segmentation Snapshot
By Therapeutic Type
• Gene Therapy
• Enzyme Replacement Therapy (ERT)
• RNA-Based Therapies (ASOs, siRNA)
• Small Molecules
• Monoclonal Antibodies
• Others
By Disease Area
• Neurological Disorders
• Metabolic Disorders
• Hematologic Disorders
• Immunological Disorders
• Cardiovascular Rare Diseases
• Others
By End User
• Hospitals
• Specialty Clinics
• Research Institutions
• Home Healthcare (For Chronic Rare Disorders)
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73179
Recent Developments
• Breakthrough gene therapies approved for spinal muscular atrophy and inherited retinal disorders.
• Expansion of rare disease clinical trials driven by AI-based patient matching.
• Novel ASO therapies progressing for neurological rare disorders.
Expert Quote - Irfan Tamboli, Business Development Executive
"The rare diseases market is entering a new era powered by gene therapies and precision medicine. With increasing global awareness and strong regulatory support, innovation is finally reaching underserved patient populations."
Conclusion
The Rare Diseases Market is set for sustained growth as next-generation therapies-especially gene, RNA-based, and targeted biologics-emerge as transformative treatment options. Companies with strong orphan drug pipelines and partnerships in genomic medicine will shape the future of this high-impact healthcare segment.
This report is also available in the following languages : Japanese (希少疾患市場), Korean (희귀 질환 시장), Chinese (罕见病市场), French (Marché des maladies rares), German (Markt für seltene Krankheiten), and Italian (Mercato delle malattie rare), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73179
Our More Reports:
Cytotoxic Drugs and HPAPI Manufacturing Market
https://exactitudeconsultancy.com/reports/72927/cytotoxic-drugs-and-hpapi-manufacturing-market
Ophthalmic Drugs Contract Manufacturing Market
https://exactitudeconsultancy.com/reports/72929/ophthalmic-drugs-contract-manufacturing-market
DNA Encoded Library Market
https://exactitudeconsultancy.com/reports/73115/dna-encoded-library-market
Bispecific Antibodies Market
https://exactitudeconsultancy.com/reports/73117/bispecific-antibodies-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rare Diseases Market to Reach USD 414.62 Billion by 2034 Driven by Gene Therapies here
News-ID: 4302417 • Views: …
More Releases from Exactitude Consultancy
Somatotropin Deficiency Market Strengthens as Long-Acting Growth Hormone Therapi …
The Somatotropin Deficiency Market is entering a high-innovation cycle as demand rises for safer, more effective, and longer-acting growth hormone therapies. With advancements in recombinant DNA technology, automated injection devices, and pediatric endocrinology screening programs, treatment for growth hormone deficiency is becoming more accessible and patient-friendly worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72048
Keyword Definition
Somatotropin deficiency-commonly known as Growth Hormone Deficiency (GHD)-is a condition characterized by inadequate secretion…
Inner Ear Diseases Market to Reach USD 3.42 Billion by 2034
Pune, India - December 2025 - The global Inner Ear Diseases Market, valued at USD 1.98 billion in 2024, is projected to reach USD 3.42 billion by 2034, growing at a 5.6% CAGR (2025-2034), according to Exactitude Consultancy. Increasing prevalence of age-related hearing loss, vestibular disorders, tinnitus, and Meniere's disease is driving market growth, along with major advances in regenerative and gene-based therapies.
Download Full PDF Sample Copy of Market Report…
Secondary Hyperparathyroidism Market Expands as CKD Burden Rises and Advanced Th …
The Secondary Hyperparathyroidism (SHPT) Market is gaining substantial momentum as chronic kidney disease (CKD) cases continue to rise worldwide. With increasing dialysis populations, improved screening programs, and the availability of advanced drugs like calcimimetics, biologics, and extended-release formulations, SHPT management is moving toward safer, more effective, and patient-friendly treatment approaches.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72046
Keyword Definition
Secondary hyperparathyroidism is a condition in which the parathyroid glands become…
Oral Oncolytics Market to Reach USD 216.54 Billion by 2034 Driven by Shift Towar …
Pune, India - December 2025 - The global Oral Oncolytics Market, valued at USD 112.37 billion in 2024, is projected to reach USD 216.54 billion by 2034, growing at a 6.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising demand for convenient, home-administered cancer treatments and strong adoption of targeted therapies are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73183
Market Summary
The Oral Oncolytics Market is expanding rapidly…
More Releases for Rare
lacit Market With Industrial Analysis by Forecast 2020-2025 | China Minmetals Ra …
This report provides in-depth study on the current state of the Global Lacit Market 2020-2025. Key players in the Global Lacit Market have been identified through the secondary research and their market share has been determined through primary and secondary research.
Global Lacit Market overview:
It is a compound made from lanthanum acetate and citric acid. LaCit market is segmented by Type, and by Application. Players, stakeholders, and other participants in the…
Rare Earth Metals Market Insights, Forecast to 2024| Great Western Minerals, Ind …
Growing demand for magnets in automobiles, and energy generation will majorly contribute to the growth of global rare earth metals market over the forecast period. The demand for rare earth magnets is majorly increasing by their consumption in electric and hybrid vehicles, and wind turbines. Increasing focus on utilizing clean and renewable energy is giving a substantial pressure on the electricity providers, to generate energy through renewable sources, which in…
Global Erbium Oxide Market 2017 - Chenguang Rare Earth, Longyi Heavy Rare-Earth, …
The report studies Erbium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022
The report Global Erbium Oxide Industry provides a comprehensive analysis of the Erbium Oxide market. The report features industry insights from experts. A detailed segmentation of the Global Erbium Oxide market has been included in the…
Global Dysprosium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals R …
The report studies Dysprosium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022
The report Global Dysprosium Oxide Industry 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has…
Global Europium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals Rar …
The report studies Europium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022
The research report titled Europium Oxide has adopted an analytical approach to evaluate the dynamics of the Europium Oxide market. It provides a detailed analysis comprising an in-depth research on the Europium Oxide market growth drivers,…
Global Rare Earth Metals Market 2017 - Beifang Rare Earth, Xiamen Tungsten, Sunl …
Rare Earth Metals Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors.
Scope of the Report:
This report focuses on the Rare Earth Metals in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.…
